MTIP leads Series B round for Oviva

Oviva, a digital provider of Type 2 diabetes treatment in Europe, has raised $21 million in Series B funding.

Oviva, a digital provider of Type 2 diabetes treatment in Europe, has raised $21 million in Series B funding. MTIP led the round.

Source: Press Release